X
19
Recordati, based in Italy, is a pharmaceutical company that stands out with its certifications from FDA.
One of their notable products is IBUPROFEN LYSINE, with a corresponding application number 21903 and regulatory information .
proudly manufactured in the
approval since 2006-04-13
Recordati's NEOPROFEN INJECTABLE;INTRAVENOUS, medication with EQ 20MG BASE/2ML (EQ 10MG BASE/ML) of IBUPROFEN LYSINE.